Study reveals how HIV virus destroys lung tissue

Up to 30 percent of HIV patients who are appropriately treated with antiretroviral therapies develop emphysema. New research from Weill Cornell Medicine investigators has uncovered a mechanism that might explain why this lung damage occurs.

Students learn to commercialize medical technologies

The Bench to Bedside Initiative program, part of Weill Cornell Medicine's entrepreneurship lab, helps medical and doctoral students, clinicians and researchers launch technologies into startups.

New method more accurately models colorectal cancer

Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center researchers have developed a preclinical model of colorectal cancer in which the disease forms in the correct anatomical location.

Jewish studies' lecturer Sampson is an NYC hero

Elissa Sampson, visiting scholar and lecturer in the Jewish Studies Program, will be honored May 18 with a Lower East Side Community Hero Award in New York City.

The Bridge architects talk design, academe and industry

Marion Weiss and Michael A. Manfredi, M.Arch. '80, cofounders of the Weiss/Manfredi architecture and landscape firm, gave an inside look at their design process of The Bridge at Cornell Tech.

Real estate titans talk development in changing world

Students and real estate professionals got a refreshingly honest view of the competitive and contentious world of development April 28 in NYC at a panel discussion.

Class gathers oral histories of Caribbean residents in Brooklyn

Oneka LaBennett's students in oral history and urban ethnography over spring break recorded the life stories of Caribbean immigrants living and working in a rapidly gentrifying part of Brooklyn.

Yimon Aye awarded young investigator cancer research prize

Yimon Aye, assistant professor of chemistry and chemical biology, has won the Pershing Square Sohn Prize for Young Investigators in Cancer Research. The prize is $600,000 over three years.

Collaborative startup will monitor pathogens in hospital settings

Biotia, a startup offering microbial surveillance for hospitals, is a joint venture between researchers at Weill Cornell Medicine and Cornell Tech, founded through the Runway Startup program at the Jacobs Technion-Cornell Institute at Cornell Tech.